Author:
Dufour Alexandre,Essayan Lucie,Thomann Céline,Petiot Emma,Gay Isabelle,Barbaroux Magali,Marquette Christophe
Abstract
AbstractThe future of organ and tissue biofabrication strongly relies on 3D bioprinting technologies. However, maintaining sterility remains a critical issue regardless of the technology used. This challenge becomes even more pronounced when the volume of bioprinted objects approaches organ dimensions. Here, we introduce a novel device called the Flexible Unique Generator Unit (FUGU), which is a unique combination of flexible silicone membranes and solid components made of stainless steel. Alternatively, the solid components can also be made of 3D printed medical-grade polycarbonate. The FUGU is designed to support micro-extrusion needle insertion and removal, internal volume adjustment, and fluid management. The FUGU was assessed in various environments, ranging from custom-built basic cartesian to sophisticated 6-axis robotic arm bioprinters, demonstrating its compatibility, flexibility, and universality across different bioprinting platforms. Sterility assays conducted under various infection scenarios highlight the FUGU’s ability to physically protect the internal volume against contaminations, thereby ensuring the integrity of the bioprinted constructs. The FUGU also enabled bioprinting and cultivation of a 14.5 cm3 human colorectal cancer tissue model within a completely confined and sterile environment, while allowing for the exchange of gases with the external environment. This FUGU system represents a significant advancement in 3D bioprinting and biofabrication, paving the path toward the sterile production of implantable tissues and organs.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Mota, C., Camarero-Espinosa, S., Baker, M. B., Wieringa, P. & Moroni, L. Bioprinting: From tissue and organ development to in vitro models. Chem. Rev. 120, 10547–10607. https://doi.org/10.1021/acs.chemrev.9b00789 (2020).
2. Mladenovska, T., Choong, P. F., Wallace, G. G. & O’Connell, C. D. The regulatory challenge of 3D bioprinting. Regen. Med. 18, 659–674. https://doi.org/10.2217/rme-2022-0194 (2023).
3. Mao, H. et al. Recent advances and challenges in materials for 3D bioprinting. Progr. Natl. Sci.: Mater. Int. 30, 618–634. https://doi.org/10.1016/j.pnsc.2020.09.015 (2020).
4. Tong, A. et al. Review of low-cost 3D Bioprinters: State of the market and observed future trends. SLAS Technol. 26, 333–366. https://doi.org/10.1177/24726303211020297 (2021).
5. Prevention, C. C. F. D. C. A. Glossary of Terms for Infection Prevention and Control in Dental Settings, https://www.cdc.gov/oralhealth/infectioncontrol/glossary.htm (2020).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献